Detalhe da pesquisa
1.
Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes.
Endocr Pract
; 27(9): 886-893, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33581327
2.
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy.
Postgrad Med J
; 95(1121): 155-161, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004045
3.
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
Gastroenterology
; 146(7): 1691-700.e3, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24583061
4.
Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?
Ann Surg Oncol
; 19(11): 3479-85, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22576067
5.
The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants.
Adv Ther
; 38(7): 3900-3910, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34061324
6.
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.
J Immunother Cancer
; 9(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563773
7.
The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong-A Territory-Wide Cohort Study.
Cancers (Basel)
; 13(9)2021 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33919277
8.
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis.
Asian Pac J Cancer Prev
; 14(11): 6585-90, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24377572